Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

118.08
Delayed Data
As of 4:00pm ET
 +1.43 / +1.23%
Today’s Change
67.81
Today|||52-Week Range
132.95
+30.79%
Year-to-Date

Today’s Trading

Previous close116.65
Today’s open118.19
Day’s range115.25 - 118.79
Volume446,347
Average volume (3 months)497,074
Market cap$5.1B
Dividend yield--
Data as of 4:00pm ET, 12/08/2016

Growth & Valuation

Earnings growth (last year)-67.92%
Earnings growth (this year)+33.18%
Earnings growth (next 5 years)+25.50%
Revenue growth (last year)+43.09%
P/E ratio121.7
Price/Sales12.92
Price/Book13.47

Competitors

 Today’s
change
Today’s
% change
DXCMDexCom Inc+1.57+2.49%
WSTWest Pharmaceutical ...+0.75+0.90%
CMDCantel Medical Corp+0.26+0.31%
NUVANuVasive Inc+1.16+1.74%
Data as of 4:02pm ET, 12/08/2016

Financials

Next reporting dateFebruary 9, 2017
EPS forecast (this quarter)$0.29
Annual revenue (last year)$329.5M
Annual profit (last year)$38.1M
Net profit margin11.58%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts


Search for Jobs